Overview

Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream

Status:
Completed
Trial end date:
2019-11-30
Target enrollment:
0
Participant gender:
All
Summary
This study was conducted to see whether there was a decrease in the degree of acne vulgaris / pimple, to find out what proportion of respondents experienced a decrease in severity and who did not experience a decrease in the severity of acne vulgaris after the use of an anti-acne cream combination containing active ingredients such as; Tretinoin 0.05% (derivatives of Vitamin A), Clindamycin 5% (antibiotics), and Dexamethasone 0.05% (anti-inflammatory) for 1 month of use.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sukma Skin Treatment
Treatments:
Clindamycin
Tretinoin
Criteria
Inclusion Criteria:

- respondents aged 14-19 years

- suffering from mild, moderate or severe degree of acne vulgaris in the face area
regardless of the respondent's skin type

- agreed to informed consent

- agreed to use a combination of anti-acne creams only and stopped all other skin
treatments on the face for at least 3 days

Exclusion Criteria:

- respondents with other skin diseases on the face such as atopic dermatitis, contact,
rosacea, viral infections, impetigo, fungal infections, acne eruption

- respondents who are suspected of having allergies to active substances contained in a
combination of anti-acne creams